Abbonarsi

ERCP performed through previously placed duodenal stents: a multicenter retrospective study of outcomes and adverse events - 14/05/18

Doi : 10.1016/j.gie.2018.01.040 
Judith Staub, MD 1, Ali Siddiqui, MD 2, Linda Jo Taylor, BS 1, David Loren, MD 2, Tom Kowalski, MD 2, Douglas G. Adler, MD 1,
1 Gastroenterology and Hepatology, University of Utah School of Medicine, Salt Lake City, Utah, USA 
2 Gastroenterology and Hepatology, Jefferson University School of Medicine, Philadelphia, Pennsylvania, USA 

Reprint requests: Douglas G. Adler, MD, FACG, AGAF, FASGE, Professor of Medicine, Director of Therapeutic Endoscopy, Director, GI Fellowship Program, Gastroenterology and Hepatology, University of Utah School of Medicine, Huntsman Cancer Center, 30N 1900E 4R118, Salt Lake City, UT 84132.Professor of MedicineDirector of Therapeutic EndoscopyDirector, GI Fellowship ProgramGastroenterology and HepatologyUniversity of Utah School of MedicineHuntsman Cancer Center30N 1900E 4R118Salt Lake CityUT84132

Abstract

Background and Aims

ERCP performed through previously placed enteral stents is an uncommon procedure without a significant amount of supporting literature and with a wide reported range of technical success. The purpose of this study was to evaluate and better define the technical feasibility and safety of performing ERCP through enteral stents in patients with combined malignant biliary and gastric outlet obstruction.

Methods

We conducted a multicenter, retrospective study on 71 patients with combined gastric outlet and biliary obstruction who underwent ERCP through a previously placed enteral stent at 2 tertiary care centers. Outcomes included but were not limited to technical success, clinical success, need for repeat ERCP, adverse events, and survival time.

Results

Overall technical success was achieved in 60 of 71 patients (85%), with technical success of 40 of 46 (87%) in type I obstructions (gastric outlet obstruction above the ampulla), 16 of 21 (76%) in type II obstructions (gastric outlet obstruction at the level of the ampulla), and 4 of 4 (100%) in type III obstructions (gastric outlet obstruction distal to the ampulla). In general, patients who achieved technical success also achieved clinical success. Adverse events occurred in 3 patients (3/71): 2 patients with acute cholangitis and 1 patient with perforation. Average survival time after the procedure was 4.6 months overall.

Conclusions

ERCP performed through enteral stents is safe, with a high technical and clinical success rate, but may be more technically challenging in the setting of type II obstructions. This procedure could be considered first line in the unique setting that a patient requires ERCP through a previously placed enteral stent for malignant gastric outlet and biliary obstruction.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: A. Siddiqui, D. Loren, T. Kowalski: Consultant for Boston Scientific. A. Siddiqui: Consultant, grant recipient from Medtronic. D. G. Adler: Consultant for Boston Scientific and Merit. All other authors disclosed no financial relationships relevant to this publication.


© 2018  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 87 - N° 6

P. 1499-1504 - giugno 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Impact of capsule endoscopy on prevention of postoperative recurrence of Crohn’s disease
  • Ze-min Han, Wei-guang Qiao, Xiu-yun Ai, Ai-min Li, Zhen-yu Chen, Xi-cheng Feng, Jie Zhang, Tian-mo Wan, Zhi-min Xu, Yang Bai, Ming-song Li, Si-de Liu, Fa-chao Zhi
| Articolo seguente Articolo seguente
  • Prediction of clinical outcomes in Crohn’s disease by using confocal laser endomicroscopy: results from a prospective multicenter study
  • Gian Eugenio Tontini, Jonas Mudter, Michael Vieth, Claudia Günther, Valentina Milani, Raja Atreya, Timo Rath, Andreas Nägel, Giorgia Hatem, Giacomo Carlo Sturniolo, Maurizio Vecchi, Markus F. Neurath, Peter R. Galle, Andrea Buda, Helmut Neumann

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.